Cargando…
Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II study
BACKGROUND: Radiotherapy is a commonly used treatment for limited-stage ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML) but showed a substantial relapse risk if the disease involves beyond-conjunctiva or bilateral conjunctivae. Systemic chemoimmunotherapy may be an alternative front...
Autores principales: | Kim, Sung-Yong, Yang, Suk-Woo, Lee, Won-Sik, Yang, Jae Wook, Oh, Sung Yong, Ahn, Hee Bae, Yang, Deok-Hwan, Park, Seong Kyu, Chang, Jee Ho, Kim, Hyo Jung, Lee, Min Joung, Cho, Seok-Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620279/ https://www.ncbi.nlm.nih.gov/pubmed/28978139 http://dx.doi.org/10.18632/oncotarget.19788 |
Ejemplares similares
-
Relapse in patients with limited‐stage ocular adnexal lymphoma treated by chemoimmunotherapy: Extended follow‐up of a phase 2 study
por: Kim, Sung‐Yong, et al.
Publicado: (2022) -
Lack of Association between Chlamydophila psittaci and Ocular Adnexal MALT Lymphoma in Korean Patients—Is the Geographic or Genetic Difference Significant?
por: Cho, Uiju, et al.
Publicado: (2021) -
Risk Potentiality of Frontline Radiotherapy Associated Cataract in Primary Ocular Adnexal Mucosa-associated Lymphoid Tissue Lymphoma
por: Cho, Won-Kyung, et al.
Publicado: (2013) -
Role of F-18 FDG PET/CT in non-conjunctival origin ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphomas
por: Park, Hye Lim, et al.
Publicado: (2019) -
Comparison of Selection and Long-term Clinical Outcomes Between Chemotherapy and Radiotherapy as Primary Therapeutic Modality for Ocular Adnexal MALT Lymphoma()
por: Jeon, Young-Woo, et al.
Publicado: (2018)